Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
BIOV | CSE | CAD | Delayed | |
BVAXF | OTC Markets | USD | Delayed | |
5LB | Frankfurt | EUR | Delayed |
BioVaxys Technology Corp. is a Canada-based clinical-stage biotechnology company. The Company is engaged in developing viral and oncology vaccine platforms, as well as immuno-diagnostics. The Company is advancing a SARS-CoV-2 vaccine based on its haptenized viral protein technology. In addition, the Company is developing its CoviDTH, a diagnostic for evaluating the presence or absence of a T-cell immune response to SARS-CoV-2, the virus that causes COVID-19. Its product portfolio includes BVX-0320, BVX-0121, BVX-0204, BVX-0918A, BVX-0918C, CoviDTH and Papilocare. BVX-0320 is an investigational new drug (IND)-stage vaccine candidate for SARS-CoV-2. The vaccine is the recombinant S1 subunit of the spike protein of SARS-CoV-2 that has been modified with a chemical called hapten, specifically, dinitrophenyl. Its CoviDTH is a disposable, diagnostic tool to identify a T-cell immune response to the presence of SARS-CoV-2. BVX-0918A is a haptenized tumor cell vaccine for ovarian cancer.
Name | Age | Since | Title |
---|---|---|---|
Adam Coutts | - | 2021 | Member of Advisory Board |
Yvelise Barrios | - | 2021 | Scientific Adviser |
Charles J. Dunton | - | 2021 | Member of Advisory Board |
Kartik Chandran | - | 2021 | Member of Scientific Advisory Board |
Shmuel Farhi | - | 2021 | Member of Scientific Advisory Board |
Anthony John Guy Dutton | 66 | 2022 | Independent Director |
James Christopher Passin | 51 | 2016 | Co-Founder, CEO, Interim CFO, Interim Company Secretary & Director |
Craig William Loverock | 52 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review